Immediate Impact

2 by Nobel laureates 4 from Science/Nature 59 standout
Sub-graph 1 of 22

Citing Papers

Trials and Tribulations of MicroRNA Therapeutics
2024 Standout
Small and long non-coding RNAs: Past, present, and future
2024 Standout
4 intermediate papers

Works of Paul Grint being referenced

Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti‐MicroRNA‐122, RG‐101
2017
LO7 : A single subcutaneous dose of 2mg/kg or 4mg/kg of RG-101, a GalNAc-conjugated oligonucleotide with antagonist activity against MIR-122, results in significant viral load reductions in chronic hepatitis C patients
2015

Author Peers

Author Last Decade Papers Cites
Paul Grint 191 243 38 155 30 765
Kenneth J. Gorelick 157 310 20 133 33 769
D. Franks 116 326 5 117 48 949
Xiao-Dan Yao 296 415 32 47 33 957
Julianne Peabody 292 243 8 218 19 713
Laura Hidalgo 75 205 5 65 30 757
Jason D. Bannan 139 208 2 113 18 973
David E. Justus 206 253 5 66 30 777
Yanhua Zeng 278 195 4 83 55 801
Juan Téllez‐Sosa 247 131 3 81 32 768
Eduardo Pareja 66 237 6 72 29 751

All Works

Loading papers...

Rankless by CCL
2026